Skip to content

Magnetic Resonance Imaging and Spectroscopy at High Field

Magnetic Resonance Imaging and Spectroscopy at High Field

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00611013
Enrollment
0
Registered
2008-02-08
Start date
2002-06-30
Completion date
Unknown
Last updated
2013-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Development of multi-purpose novel imaging protocols

Brief summary

Evaluating novel MR imaging techniques on volunteers.

Detailed description

The aim of this study is twofold. The first aim is to evaluate new MRI techniques developed by the investigators of this protocol on human volunteers. The second aim is to assist other investigators who need to use MR images obtained on this device for their own research. MR images and/or spectroscopy data will be acquired from the participants in this protocol.

Interventions

DEVICEMagnetic Resonance Imaging

Some participants may receive MRI contrast agent, 0.1 mmol/kg

Sponsors

University of California, Irvine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy normal volunteers for imaging protocol optimization.

Exclusion criteria

* Patients with implanted surgical clips (hemostatic clips) or other ferromagnetic material, * Patients engaged in occupations or activities which may cause accidental lodging of ferromagnetic materials, or who may have imbedded metal fragments from military activities, * Patients with permanent (tattoo) eye-liner or with facial make-up (severe eye irritation has been reported), * Patients with compromised thermoregulatory systems (e.g. certain cancer patients), * Patients with metallic implants, because they may cause artifacts in diagnostic images due to magnetic field distortion, * Patients with implanted prosthetic heart valves, * Patients with pacemakers, neuro-stimulation devices, * Pregnant patients (the safety of magnetic resonance examination has not been completely established for embryos and fetuses), * Subjects who have received orthodontic work involving ferromagnetic materials, * Subjects who have claustrophobia, and * The patients unwilling to participate in the study or fail to sign the consent form. * Subjects who are pregnant or breast-feeding will be excluded from the contrast enhanced MRI studies. * Subjects who had allergic response to contrast agents previously will be excluded from contrast enhanced MRI studies. * Subjects with known history of asthma, allergic conditions, severe renal insufficiency, sickle cell anemia, chronic hemolytic anemia, gastrointestinal disorders will also be excluded from contrast enhanced MRI studies.

Design outcomes

Primary

MeasureTime frame
General purpose novel magnetic resonance imaging contrasts, developments for improved magnetic resonance image quality10 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026